País: Reino Unido
Língua: inglês
Origem: HMA (Heads of Medicines Agencies)
live infectious bursal disease virus,strain GM97 10 mg
Fort Dodge Animal Health
QI01AD09
Oral suspension
Avian infectious bursal disease virus (Gumboro disease)
Chicken Broilers
2011-04-08
Revised: July 2013 AN: 00576/2012 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Poulvac Bursa (DK) Poulvac Bursa Plus vakcina A.U.V. (HU) Poulvac Bursa Plus (all other countries) Lyophilisate for suspension in drinking water. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance Per dose Live Infectious Bursal Disease Virus, strain V877 10 2.2 - 10 3.4 EID 50 * * 50% egg infective dose EXCIPIENTS For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Lyophilisate for suspension in drinking water. Appearance : brownish tablets. 4. CLINICAL PARTICULARS 4.0 TARGET SPECIES Chickens, from 10 days of age. 4.1 INDICATIONS FOR USE For the active immunisation of chickens with maternal antibody levels of ≤ 500 ELISA units, to reduce mortality and bursal lesions of Gumboro disease. The onset of immunity has been shown by challenge from 14 days after vaccination and the duration of immunity is 32 days. 4.2 CONTRA-INDICATIONS Do not vaccinate sick birds. Do not use in infected flocks showing clinical signs. 4.3 SPECIAL WARNINGS Use only in flocks with maternal antibody levels of ≤ 500 ELISA units. The optimum day of vaccination is calculated according to the Kouwenhoven’s formula (see section 4.5. Special precautions for use). Due to its residual pathogenicity to the bursae the vaccine should be used only in case of outbreaks of very virulent IBDV strains. Revised: July 2013 AN: 00576/2012 Page 2 of 5 4.4 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE I Leia o documento completo